Victoria Coleman-Cowger, Emmes' Therapeutic Area Scientific Director, Neuroscience, shares insights on our pivotal role in advancing clinical neuroscience research. Victoria highlights the importance of collaboration and innovation, particularly in treating underserved populations and exploring novel interventions such as psychedelics. Emmes continues to drive progress in clinical neuroscience by tailoring approaches to meet the unique needs of each trial. Visit https://hubs.la/Q02BX0SW0 to learn more. #ClinicalTrials #NeuroscienceResearch #InnovativeHealthcare
Emmes’ Post
More Relevant Posts
-
𝗧𝗮𝗿𝗴𝗲𝘁𝗶𝗻𝗴 𝗻𝗲𝘂𝗿𝗼𝗶𝗻𝗳𝗹𝗮𝗺𝗺𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝗻𝗲𝘂𝗿𝗼𝘀𝗰𝗶𝗲𝗻𝗰𝗲 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 Current treatment options can alleviate symptoms but do not treat the root cause of neurodegeneration, and therefore cannot prevent its onset or progression. Neuroinflammation represents a potential therapeutic target, but further research is necessary in order to develop a greater understanding of the process and its relationship to neuronal damage. Read more about this in our white paper here: https://okt.to/d71z4T #WhitePaper #Neuroinflammation #Neurodegeneration
To view or add a comment, sign in
-
Biomedical research with NHPs is important for advances in neuroscience. Read more about a proposed framework for international collaboration for #NHP neuroscience #research. https://lnkd.in/gPb89p4j #neurosciene #nonhumanprimates
To view or add a comment, sign in
-
-
✌🏼 NeuroClues’ Clinical Roundtables #2: Decoding Concussion with Eye movements! ⏳As a reminder, we are organizing three roundtables to discuss issues related to neurological care. Our aim is to foster an engaging environment where peers can freely discuss and share valuable insights, contributing to the advancement of neurological research. Our ultimate goal is to share these exclusive insights at the end of these roundtables during the clinical get-together we are organizing. There, you can hear first-hand the exclusive insights given during those conversations. 🧠 With that excitement in mind, we're moving forward with our second topic: Could eye movements hold the key to a more accurate patient workup when suspecting a #concussion? Stay tuned for updates on this insightful discussion! 📚For those keen on getting a head start, we invite you to delve into our literature review on the relevance of eye tracking in concussion. Link in the comments. 👇 #biomarkers #neuroscience #eyetracking
To view or add a comment, sign in
-
-
Today kicks off the 9th Neurological Disorders Summit in Barcelona, which will bring together neuroscientists and physicians from across the world to share their research and perspectives. With a focus on #epilepsy, #Parkinsons, #Alzheimers, and other neurological disorders, the Summit will provide an overview of the cutting-edge technologies being used to address therapeutic and theoretical issues in #neuroscience. We look forward to hearing about the new and novel research that will emerge from these collaborations and presentations, as well as the transformative impact they will have on the diagnosis, treatment, and understanding of neurological disorders. See the agenda: https://lnkd.in/e_yEZXe
To view or add a comment, sign in
-
-
🧠 Delving into the intricate web of mammalian brains! Moritz Helmstaedter (@max-planck-institute-for-brain-research-frankfurt-am-main) explores the complexity of nerve cell communication, uncovering one of the most intricate networks in existence. The rules governing the creation and operation of this network pose fascinating questions in neuroscience. In this #videopublication, he shares insights into studying the wiring of the cerebral cortex, using electron microscopy for a 3D image dataset. Contrary to popular belief, the mammalian cortex's wiring isn't random – neurons make strategic connections. This precision opens doors for further research, potentially shedding light on psychiatric diseases. 🔍 https://lnkd.in/dTE-KiAJ #Neuroscience #BrainResearch #CerebralCortex
How Is the Cerebral Cortex of Mammalian Brains Wired?
lt.org
To view or add a comment, sign in
-
Psychedelic Neuroscience Demystified: How Psychedelics Alter Consciousness and Produce Therapeutic Effects Become a neuroscience-informed participant in the psychedelic space. Clinicians and therapists have an increasing interest in psychedelic therapies. However, many don’t know the scientific evidence on how they work at the level of the brain. The information in this special course can help inform your therapeutic approaches and how you can better guide your clients […] The post Psychedelic Neuroscience Demystified: How Psychedelics Alter Consciousness and Produce Therapeutic Effects appeared first on Psychedelics Today.
Psychedelic Neuroscience Demystified: How Psychedelics Alter Consciousness and Produce Therapeutic Effects
https://psychedelicstoday.com
To view or add a comment, sign in
-
NPR reports on the blending of art and science in the treatment of neurological disorders. Immersive medicine (IMM) is the use of immersive media in the delivery and direct construction of digital and physical therapeutics. The data on IMM’s effectiveness is staggering, making it clear that there is massive potential when media and medicine are thoughtfully combined. This NPR Canvas episode highlights the potential of some of these burgeoning therapies, focusing in on neuroarts. Episode Description: “Your Brain On Art: How The Arts Transform Us,” shows both the growth and importance of the field that connects the arts and our health. Jeffrey Brown (NPR) visited the Johns Hopkins School of Medicine in Baltimore to experience firsthand the progress being made in this new field of neuroscience. Episode Link: https://lnkd.in/dviGgZgz #immersivemedicine #powerofplay #arttherapy #musictherapy #neuroscience #stressreduction #anxietyrelief #depressionsupport
To view or add a comment, sign in
-
-
Neurological diseases have become a leading cause of poor health and disability worldwide, underscoring the urgent need for enhanced research and innovative approaches in #neuroscience. Despite efforts focused on advancing treatment, progress has been disappointingly slow in part due to high risk of failure and often lengthy development timelines. When neuroscience drug developers are able to demonstrate confidence with solid early-to mid-stage data, investors are more inclined to engage, recognizing substantial market potential. Learn more in this STAT article as our Chief Executive Officer Bruce Leuchter, M.D., describes a private equity model, like the one we embrace, to support the advancement of promising neurotherapeutics: https://lnkd.in/erMQz5fP
To view or add a comment, sign in
-
-
Due to the high risk of failure and often lengthy development timelines, many investors have historically been reluctant to support the development of novel technologies for neurological diseases until early-stage clinical data demonstrate a strong likelihood of success. In this STAT article, I outline a private equity model for neurotherapeutics based on a four-step process – search, evaluate, invest, and develop. This approach, embraced by Neurvati Neurosciences, positions assets for a broad range of development opportunities. Read here: https://lnkd.in/e-8hk7mm
Neurological diseases have become a leading cause of poor health and disability worldwide, underscoring the urgent need for enhanced research and innovative approaches in #neuroscience. Despite efforts focused on advancing treatment, progress has been disappointingly slow in part due to high risk of failure and often lengthy development timelines. When neuroscience drug developers are able to demonstrate confidence with solid early-to mid-stage data, investors are more inclined to engage, recognizing substantial market potential. Learn more in this STAT article as our Chief Executive Officer Bruce Leuchter, M.D., describes a private equity model, like the one we embrace, to support the advancement of promising neurotherapeutics: https://lnkd.in/erMQz5fP
To view or add a comment, sign in
-